Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: Insights from the CREDENCE trial
27 August 2021 (00:00 - 00:00)
Organised by:
About the speaker
The George Institute for Global Health, Sydney (Australia)
36 More presentations in this session
Assistant Professor O. Kiss (Budapest, HU)
Doctor S. Fyyaz (London, GB)
Doctor G. Parry-Williams (London, GB)
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August - 30 August 2021
You may be interested in
Congress Presentation
Congress Presentation
